Bortezomib action in multiple myeloma: microRNA-mediated synergy (and miR-27a/CDK5 driven sensitivity)?
Blood Cancer J
.
2012 Aug 24;2(8):e83.
doi: 10.1038/bcj.2012.31.
Authors
E Ballabio
1
,
M Armesto
,
C E Breeze
,
L Manterola
,
M Arestin
,
D Tramonti
,
C S R Hatton
,
C H Lawrie
Affiliation
1
Lymphoid Malignancy Research Group, Nuffield Department of Clinical Laboratory Sciences, University of Oxford, John Radcliffe Hospital, Oxford, UK.
PMID:
22922378
PMCID:
PMC3432485
DOI:
10.1038/bcj.2012.31
No abstract available